Shields A - Search Results

1

Identifying Core Outcome Domains in Chronic Skin Disease Using the Best-Worst Scaling Method.

Shields A, Barg FK, Begolka WS, Sage K, Druby K, Gondo GC, Margolis DJ, Pusic AL, Barbieri JS. Shields A, et al. JAMA Dermatol. 2024 Apr 1;160(4):441-446. doi: 10.1001/jamadermatol.2023.6245. JAMA Dermatol. 2024. PMID: 38381409

2

Spironolactone use for acne is not associated with an increased risk of venous thromboembolism: A matched, retrospective cohort study.

Shields A, Flood K, Barbieri JS. Shields A, et al. J Am Acad Dermatol. 2023 Jun;88(6):1396-1397. doi: 10.1016/j.jaad.2023.02.028. Epub 2023 Feb 25. J Am Acad Dermatol. 2023. PMID: 36842507 Free PMC article. No abstract available.

3

Content analysis of health-related quality-of-life patient-reported outcome measures used in patients with atopic dermatitis.

Shields A, Yoon J, Barbieri JS. Shields A, et al. J Am Acad Dermatol. 2023 Oct;89(4):817-820. doi: 10.1016/j.jaad.2023.05.069. Epub 2023 Jun 7. J Am Acad Dermatol. 2023. PMID: 37295509 Free PMC article. No abstract available.

4

Effectiveness of spironolactone for women with acne vulgaris (SAFA) trial: a critically appraised topic.

Shields A, Barbieri JS. Shields A, et al. Br J Dermatol. 2023 Oct 25;189(5):509-510. doi: 10.1093/bjd/ljad270. Br J Dermatol. 2023. PMID: 37503674 Free PMC article. No abstract available.

5

From Breakouts to Bargains: Strategies for Patient-Centered, Cost-effective Acne Care.

Shields A, Barbieri JS. Shields A, et al. Cutis. 2023 Aug;112(2):E24-E29. doi: 10.12788/cutis.0844. Cutis. 2023. PMID: 37820334 Free PMC article. Review.

6

The role of oral nutraceuticals as adjunctive therapy to reduce side effects from isotretinoin: A systematic review.

Shields A, Ly S, Wafae B, Chang YF, Manjaly P, Archila M, Heinrich C, Drake L, Mostaghimi A, Barbieri JS. Shields A, et al. J Am Acad Dermatol. 2024 Mar;90(3):612-615. doi: 10.1016/j.jaad.2023.10.037. Epub 2023 Oct 21. J Am Acad Dermatol. 2024. PMID: 37871802 No abstract available.

7

Safety and Effectiveness of Oral Nutraceuticals for Treating Acne: A Systematic Review.

Shields A, Ly S, Wafae B, Chang YF, Manjaly P, Archila M, Heinrich C, Drake L, Mostaghimi A, Barbieri JS. Shields A, et al. JAMA Dermatol. 2023 Dec 1;159(12):1373-1382. doi: 10.1001/jamadermatol.2023.3949. JAMA Dermatol. 2023. PMID: 37878272 Free PMC article.

8

Evaluation of DermSat-7 for Assessing Treatment Satisfaction in Patients with Acne.

Shields A, Armstrong AW, Kaur MN, Layton A, Thiboutot D, Tan J, Barbieri JS. Shields A, et al. JAMA Dermatol. 2024 Jan 1;160(1):88-92. doi: 10.1001/jamadermatol.2023.4481. JAMA Dermatol. 2024. PMID: 37991774 Free PMC article.

9

Evaluation of Stigma Toward Individuals With Acne.

Shields A, Nock MR, Ly S, Manjaly P, Mostaghimi A, Barbieri JS. Shields A, et al. JAMA Dermatol. 2024 Jan 1;160(1):93-98. doi: 10.1001/jamadermatol.2023.4487. JAMA Dermatol. 2024. PMID: 38055249 Free PMC article.

10

Quality of patient-reported outcome measures for grading acne scars and dark marks: a COSMIN review.

Urbonas R, Shields A, Ly S, Choe J, Heinrich C, Keri J, Barbieri JS. Urbonas R, et al. Among authors: shields a. Arch Dermatol Res. 2024 Jan 10;316(2):70. doi: 10.1007/s00403-024-02815-6. Arch Dermatol Res. 2024. PMID: 38198016 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

807 results

Search Page

Filters